Byrne Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Byrne Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$1K	–	571
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	494
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	510
2022 Q1	$3K	Hold	200	–	–	﹤0.01%	491
2021 Q4	$3K	Buy	+200	New	+$4.8K	﹤0.01%	496

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Byrne Asset Management's DMTK Position: Q4 2022 in Review

Byrne Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 200 shares — an estimated $1K sold.

Byrne Asset Management first reported a position in DMTK in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Byrne Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Byrne Asset Management sold 200 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $1K.
Byrne Asset Management first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Byrne Asset Management's DermTech, Inc. Common Stock position peaked at $3K in Q1 2022.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Byrne Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.